Bangladesh: Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility

Sovereign Project | 55077-001

The project will provide the Government of Bangladesh with timely financing for procuring safe and effective vaccines against the coronavirus disease (COVID-19) based on an agreed list of eligible expenditures. It will utilize the rapid response component (RRC) under the Asia Pacific Vaccine Access Facility (APVAX). Ongoing technical assistance (TA) will help strengthen the vaccine delivery system. The project is aligned with three operational priorities of the Asian Development Bank (ADB) Strategy 2030: (i) addressing remaining poverty and reducing inequalities, (ii) accelerating progress in gender equality, and (iii) fostering regional cooperation and integration. It is also aligned with ADB's country partnership strategy for Bangladesh, 2016-2020 in the priority areas of improving human capital and health care, and promoting gender equality

Project Details

Project Name Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility
Project Number 55077-001
Country / Economy Bangladesh
Project Status Active
Project Type / Modality of Assistance Loan
Source of Funding / Amount
Loan 4078-BAN: Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility
Concessional ordinary capital resources lending US$ 470.00 million
Loan 4079-BAN: Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility
Ordinary capital resources US$ 470.00 million
Strategic Agendas Inclusive economic growth
Regional integration
Drivers of Change Gender Equity and Mainstreaming
Knowledge solutions
Partnerships
Sector / Subsector

Health / Disease control of communicable disease
Gender Equity and Mainstreaming Effective gender mainstreaming
Description The project will provide the Government of Bangladesh with timely financing for procuring safe and effective vaccines against the coronavirus disease (COVID-19) based on an agreed list of eligible expenditures. It will utilize the rapid response component (RRC) under the Asia Pacific Vaccine Access Facility (APVAX). Ongoing technical assistance (TA) will help strengthen the vaccine delivery system. The project is aligned with three operational priorities of the Asian Development Bank (ADB) Strategy 2030: (i) addressing remaining poverty and reducing inequalities, (ii) accelerating progress in gender equality, and (iii) fostering regional cooperation and integration. It is also aligned with ADB's country partnership strategy for Bangladesh, 2016-2020 in the priority areas of improving human capital and health care, and promoting gender equality
Project Rationale and Linkage to Country/Regional Strategy Since the first case of COVID-19 was confirmed in Bangladesh in March 2020, 776,257 cases have been confirmed and 12,005 people have died from the virus as of 11 May 2021. The pandemic has resulted in high costs to the country's overall health, well-being, and the economy. Bangladesh is currently experiencing a second wave, which has led to a rapid spike in new cases, with the highest number of deaths (112) in a single day on 19 April 2021. The resurgence in infections threatens to incur prolonged health and economic costs. Recognizing the need for vaccinations, the government acted swiftly to roll out vaccinations starting 7 February 2021. The government has secured a pipeline of 33.2 million doses and more than 9.3 million people have been vaccinated as of 9 May 2021. The government aims to inoculate 80% of its population. However, Bangladesh's vaccine needs have not been fully met and a significant share of the targeted population is yet to be vaccinated. It requires timely financing support to procure safe and effective vaccines, and avert prolonged risks from the pandemic.
Impact Accelerated health, social, and economic recovery of the COVID-19 affected population in Bangladesh
Project Outcome
Description of Outcome Target populations vaccinated against COVID-19
Progress Toward Outcome
Implementation Progress
Description of Project Outputs Safe and effective COVID-19 vaccines delivered
Status of Implementation Progress (Outputs, Activities, and Issues)
Geographical Location Nation-wide
Safeguard Categories
Environment C
Involuntary Resettlement C
Indigenous Peoples C
Summary of Environmental and Social Aspects
Environmental Aspects The project will support the procurement of vaccines and will not entail civil works or other activities with potential for significant adverse impacts on the environment.
Involuntary Resettlement The project will not require any land acquisition or lead to any involuntary resettlement impacts or involuntary land use restriction.
Indigenous Peoples The tribes, minor races, ethnic sects, and ethnic communities will not be targeted as a distinct and vulnerable IP group but may benefit as individual IPs.
Stakeholder Communication, Participation, and Consultation
During Project Design
During Project Implementation The participation plan will not be prepared because while the participation of CSOs has been envisaged, CSOs are not the major interest holder in this program.
Business Opportunities
Procurement Procurement will be undertaken in a manner consistent with simplified and expedient procedures permitted under the ADB Procurement Policy (2017, as amended from time to time) and Procurement Regulations for ADB Borrowers (2017, as amended from time to time). Since the project will be financed under APVAX, ADB member country eligibility restrictions will be waived and universal procurement will apply. The procurement of a proportion of the vaccines may be done through COVAX. In addition, given the severely constrained vaccine market, the MOHFW may negotiate directly with vaccine manufacturers to agree on bilateral contracts, and direct contracting with UNICEF. Before being confirmed as an eligible expenditure under the loan, ADB will review all bilateral vaccine agreements. Value for money in procurement will be achieved by (i) selecting vaccines that are best suited to the domestic supply chain; (ii) identifying vaccines that will efficiently meet the project disbursement conditions; (iii) engaging with manufacturers that have advantageous vaccine delivery timelines; and (iv) entering into agreements on terms and conditions that are reasonable, noting the currently constrained market for vaccines globally. ADB's Anticorruption Policy (1998, as amended to date) will apply to all contracts to be financed under the loan.
Responsible ADB Officer Jain, Nishant
Responsible ADB Department South Asia Department
Responsible ADB Division Human and Social Development Division, SARD
Executing Agencies
Finance Division, Ministry of Finance
Mr.Molla Mansur Ahmed
[email protected]
Bangladesh Secretariat, Dhaka-1000
Bangladesh
Timetable
Concept Clearance 30 Dec 2022
Fact Finding 29 Mar 2021 to 05 Apr 2021
MRM 10 May 2021
Approval 22 Jun 2021
Last Review Mission -
Last PDS Update 22 Jun 2021

Loan 4078-BAN

Milestones
Approval Signing Date Effectivity Date Closing
Original Revised Actual
22 Jun 2021 24 Jun 2021 05 Jul 2021 30 Nov 2024 - -
Financing Plan Loan Utilization
Total (Amount in US$ million) Date ADB Others Net Percentage
Project Cost 470.00 Cumulative Contract Awards
ADB 470.00 17 Jun 2022 447.27 0.00 95%
Counterpart 0.00 Cumulative Disbursements
Cofinancing 0.00 17 Jun 2022 446.97 0.00 95%

Loan 4079-BAN

Milestones
Approval Signing Date Effectivity Date Closing
Original Revised Actual
22 Jun 2021 24 Jun 2021 05 Jul 2021 30 Nov 2024 - -
Financing Plan Loan Utilization
Total (Amount in US$ million) Date ADB Others Net Percentage
Project Cost 470.00 Cumulative Contract Awards
ADB 470.00 17 Jun 2022 300.00 0.00 64%
Counterpart 0.00 Cumulative Disbursements
Cofinancing 0.00 17 Jun 2022 452.25 0.00 96%

Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.

The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.

The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.

In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.

Title Document Type Document Date
Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility: Updated Project Administration Manual Project/Program Administration Manual Sep 2021
Amendment to the Loan Agreements for Loan 4078-BAN and 4079-BAN: Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility Loan Agreement (Ordinary Resources) Aug 2021
Loan Agreement (Ordinary Operations [Concessional]) for Loan 4078-BAN: Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility Loan Agreement (Ordinary Resources) Jun 2021
Loan Agreement (Ordinary Operations) for Loan 4079-BAN: Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility Loan Agreement (Ordinary Resources) Jun 2021
Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility: Gender Equality and Social Inclusion Action Plan Gender Action Plans May 2021
Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility: Report and Recommendation of the President Reports and Recommendations of the President May 2021
Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility: Project Administration Manual Project/Program Administration Manual May 2021
Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility: Procurement Plan Procurement Plans Mar 2021

Safeguard Documents See also: Safeguards
Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.

None currently available.

Evaluation Documents See also: Independent Evaluation

None currently available.

Related Publications

None currently available.

The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.

Requests for information may also be directed to the InfoUnit.

Tenders

No tenders for this project were found.

Contracts Awarded

No contracts awarded for this project were found